Nov 13, 2025 02:04PM Lilly and Novo Nordisk say no affiliation with Mangoceuticals (MGRX)

Nov 13, 2025 07:00AM Mangoceuticals launches direct access programs for Zepbound and Wegovy

Aug 4, 2025 09:07AM Mangoceuticals (MGRX) announces termination of Navy Wharf deal

Jun 13, 2025 04:41PM Mangoceuticals (MGRX) Files $150M Mixed Shelf

May 30, 2025 04:36PM Mangoceuticals (MGRX) Files for 4.46M Share Offering by Selling Stockholders

May 27, 2025 09:05AM Mangoceuticals' (MGRX) MGX-0024 delivers 100% respiratory survival in studies

Apr 28, 2025 09:36AM ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market

Apr 26, 2025 10:54AM CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Techno

Apr 25, 2025 10:26AM ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the

Apr 25, 2025 09:01AM Mangoceuticals (MGRX) Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Gro

Apr 22, 2025 01:55PM CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

Mar 25, 2025 09:00AM Mangoceuticals (MGRX) Утеукы Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada

Feb 12, 2025 08:03AM Mangoceuticals (MGRX) Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water

Feb 6, 2025 07:02AM Mangoceuticals (MGRX) Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research

Dec 4, 2024 07:00AM Mangoceuticals (MGRX) Investigates Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

Oct 22, 2024 08:05AM Mangoceuticals (MGRX) Announces Formation of Strategy and Alternatives Committee

Oct 21, 2024 05:10PM Mangoceuticals (MGRX) Responds to and Refutes Recent Claims Made by Eli Lilly

Oct 18, 2024 08:45AM Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024

Oct 14, 2024 06:02AM Mangoceuticals (MGRX) Announces 1:15 Reverse Share Split

Oct 3, 2024 08:30AM Mangoceuticals (MGRX) Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

Oct 1, 2024 07:31AM Mangoceuticals (MGRX) Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment

Aug 16, 2024 04:48PM Mangoceuticals (MGRX) Files for 16.17M Share Offering by Selling Stockholders

Aug 13, 2024 04:00PM Mangoceuticals (MGRX) Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent

Aug 8, 2024 08:00AM MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market

Jul 16, 2024 08:20AM Mangoceuticals (MGRX) Wins Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts

Jul 12, 2024 01:31PM Mangoceuticals (MGRX) Appoints Douglas Christianson as Director of the Medical Research and Product Innovation Department

Jul 11, 2024 08:16AM Mangoceuticals (MGRX) Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets